Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study-Reference-Cited by-同舟云学术

Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study

Published:2024-02-06 Issue:3 Volume:38 Page:570-578
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

England James T.^ORCID,Szuber Natasha,Sirhan Shireen^ORCID,Dunne Tom,Cerquozzi Sonia,Hill Madeleine^ORCID,Villeneuve Pierre J. A.^ORCID,Ho Jenny M.,Sadikovic Bekim,Bhai Pratibha,Krishnan Nupur,Dowhanik Sebastian,Hillis Chris,Capo-Chichi Jose-Mario,Tsui Hubert,Cheung Verna,Gauthier Karine,Sibai Hassan,Davidson Marta B.,Bankar Aniket,Kotchetkov Rouslan,Gupta Vikas^ORCID,Maze Dawn^ORCID

Funder

Princess Margaret Cancer Foundation

Tony and Elizabeth Comper Foundation

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41375-024-02155-4.pdf

Reference34 articles.

1. Spivak JL. Myeloproliferative neoplasms. N Engl J Med. 2017;376:2168–81.

2. Segura-Díaz A, Stuckey R, Florido Y, González-Martín JM, López-Rodríguez JF, Sánchez-Sosa S, et al. Thrombotic risk detection in patients with polycythemia vera: the predictive role of DNMT3A/TET2/ASXL1 mutations. Cancers. 2020;12:934.

3. Gangat N, Caramazza D, Vaidya R, George G, Begna K, Schwager S, et al. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status. J Clin Oncol. 2011;29:392–7.

4. Grinfeld J, Nangalia J, Baxter EJ, Wedge DC, Angelopoulos N, Cantrill R, et al. Classification and personalized prognosis in myeloproliferative neoplasms. N Engl J Med. 2018;379:1416–30.

5. Tefferi A, Guglielmelli P, Lasho TL, Gangat N, Ketterling RP, Pardanani A, et al. MIPSS70+ version 2.0: mutation and karyotype-enhanced international prognostic scoring system for primary myelofibrosis. J Clin Oncol. 2018;36:1769.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloproliferative neoplasms: young patients, current data and future considerations;Annals of Hematology;2024-08-07

2. Polycythemia vera: past, present and future;Leukemia & Lymphoma;2024-06-13

3. Myeloproliferative neoplasms in the adolescent and young adult population: A comprehensive review of the literature;British Journal of Haematology;2024-06-10